WHO ICTRP trial
A randomized controlled comparison study of carbon nanoparticles and indocyanine…
ChiCTR2100054262 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2100054262 |
|---|---|
| Public title | A randomized controlled comparison study of carbon nanoparticles and indocyanine green for sentinel lymph node biopsy in early stage cervical cancer |
| Scientific title | A randomized controlled comparison study of carbon nanoparticles and indocyanine green for sentinel lymph node biopsy in early stage cervical cancer |
| Primary sponsor | National Cancer Center/Peking Union Medical College Cancer Hospital, Chinese Academy of Medical Sciences |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Diagnostic test |
| Phase | 0 |
| Countries | China |
| Conditions | Cervical cancer |
| Interventions | Gold Standard:Systematic pelvic lymph node dissection, and routine pathological examination of each dissected lymph node.;Index test:Sentinel lymph node biopsy (72 patients received nanocarbon SLNB and 72 patients received ICG fluorescence… |
| Registration date | Dec 12, 2021 |
| Target size | Target condition:0;Difficult condition:0 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: